The Role of Imaging in Prostate Cancer Care Pathway: Novel Approaches to Urologic Management Challenges Along 10 Imaging Touch Points.

[1]  C. De Nunzio,et al.  An update on prostate biopsy in the era of magnetic resonance imaging. , 2018, Minerva urologica e nefrologica = The Italian journal of urology and nephrology.

[2]  D. Margolis,et al.  MRI‐Targeted or Standard Biopsy for Prostate‐Cancer Diagnosis , 2018, The New England journal of medicine.

[3]  C. Stief,et al.  Outcome after PSMA PET/CT based radiotherapy in patients with biochemical persistence or recurrence after radical prostatectomy , 2018, Radiation Oncology.

[4]  J. Barentsz,et al.  PD23-02 THE FUTURE TRIAL; A MULTICENTER RCT ON THREE TECHNIQUES OF MRI TARGETED PROSTATE BIOPSY. , 2018 .

[5]  Current application and future perspectives of PSMA PET imaging in prostate cancer , 2018 .

[6]  Marco Riboldi,et al.  Multimodal image registration for the identification of dominant intraprostatic lesion in high-precision radiotherapy treatments. , 2017, The British journal of radiology.

[7]  M. Roobol,et al.  Risk‐stratification based on magnetic resonance imaging and prostate‐specific antigen density may reduce unnecessary follow‐up biopsy procedures in men on active surveillance for low‐risk prostate cancer , 2017, BJU international.

[8]  P. Kellokumpu-Lehtinen,et al.  Diffusion-weighted MRI Provides a Useful Biomarker for Evaluation of Radiotherapy Efficacy in Patients with Prostate Cancer. , 2017, Anticancer research.

[9]  K. Pienta,et al.  Prostate Cancer Local Recurrence Detected With Both 18F-Fluciclovine and PSMA-targeted 18F-DCFPyL PET/CT. , 2017, Urology.

[10]  I. Balslev,et al.  Where Do Transrectal Ultrasound- and Magnetic Resonance Imaging-guided Biopsies Miss Significant Prostate Cancer? , 2017, Urology.

[11]  A. Kawashima,et al.  Prostate cancer: state of the art imaging and focal treatment. , 2017, Clinical radiology.

[12]  G. Israel,et al.  Role of MRI in the Use of an Absorbable Hydrogel Spacer in Men Undergoing Radiation Therapy for Prostate Cancer: What the Radiologist Needs to Know. , 2017, AJR. American journal of roentgenology.

[13]  Y. Huan,et al.  A meta-analysis of use of Prostate Imaging Reporting and Data System Version 2 (PI-RADS V2) with multiparametric MR imaging for the detection of prostate cancer , 2017, European Radiology.

[14]  B. Fei,et al.  Molecular imaging and fusion targeted biopsy of the prostate , 2017, Clinical and Translational Imaging.

[15]  M. Mischi,et al.  Multiparametric dynamic contrast-enhanced ultrasound imaging of prostate cancer , 2016, European Radiology.

[16]  A. Ravi,et al.  Trends in targeted prostate brachytherapy: from multiparametric MRI to nanomolecular radiosensitizers , 2016, Cancer Nanotechnology.

[17]  T. Polascik,et al.  Focal Cryotherapy for Localized Prostate Cancer. , 2016, Archivos espanoles de urologia.

[18]  C. Reimann,et al.  Nuclear Medicine Imaging of Prostate Cancer , 2016, RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren.

[19]  P. Choyke,et al.  Multiparametric Magnetic Resonance Imaging of Recurrent Prostate Cancer , 2016, Topics in magnetic resonance imaging : TMRI.

[20]  Steve Y. Cho,et al.  PSMA-Based [18F]DCFPyL PET/CT Is Superior to Conventional Imaging for Lesion Detection in Patients with Metastatic Prostate Cancer , 2016, Molecular Imaging and Biology.

[21]  M. Ferrari,et al.  18F-FACBC (anti1-amino-3-18F-fluorocyclobutane-1-carboxylic acid) versus 11C-choline PET/CT in prostate cancer relapse: results of a prospective trial , 2016, European Journal of Nuclear Medicine and Molecular Imaging.

[22]  D. Margolis,et al.  PI-RADS Prostate Imaging - Reporting and Data System: 2015, Version 2. , 2016, European urology.

[23]  A. Jemal,et al.  Cancer statistics, 2016 , 2016, CA: a cancer journal for clinicians.

[24]  Ö. Acar,et al.  Prostate‐specific membrane antigen‐based imaging in prostate cancer: Impact on clinical decision making process , 2015, The Prostate.

[25]  Esther Mena,et al.  Initial Evaluation of [18F]DCFPyL for Prostate-Specific Membrane Antigen (PSMA)-Targeted PET Imaging of Prostate Cancer , 2015, Molecular Imaging and Biology.

[26]  Bing Hu,et al.  Transrectal real-time elastography-guided transperineal prostate biopsy as an improved tool for prostate cancer diagnosis. , 2015, International journal of clinical and experimental medicine.

[27]  Danny Vesprini,et al.  Long-term follow-up of a large active surveillance cohort of patients with prostate cancer. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  Robert Rohling,et al.  MR elastography of prostate cancer: quantitative comparison with histopathology and repeatability of methods , 2014, NMR in biomedicine.

[29]  P. Choyke,et al.  Identification of threshold prostate specific antigen levels to optimize the detection of clinically significant prostate cancer by magnetic resonance imaging/ultrasound fusion guided biopsy. , 2014, The Journal of urology.

[30]  B. Turkbey,et al.  Multiparametric magnetic resonance imaging outperforms the Prostate Cancer Prevention Trial risk calculator in predicting clinically significant prostate cancer , 2014, Cancer.

[31]  J. Cho,et al.  Shear Wave Elastography for Detection of Prostate Cancer: A Preliminary Study , 2014, Korean journal of radiology.

[32]  Hans Garmo,et al.  Radical prostatectomy or watchful waiting in early prostate cancer. , 2014, The New England journal of medicine.

[33]  E. Crawford,et al.  Challenges and recommendations for early identification of metastatic disease in prostate cancer. , 2014, Urology.

[34]  M. Haider,et al.  Imaging in prostate carcinoma. , 2013, Hematology/oncology clinics of North America.

[35]  P. Muzzio,et al.  Utility of choline positron emission tomography/computed tomography for lymph node involvement identification in intermediate- to high-risk prostate cancer: a systematic literature review and meta-analysis. , 2013, European urology.

[36]  J. Kotzerke,et al.  18F-Choline, 11C-choline and 11C-acetate PET/CT: comparative analysis for imaging prostate cancer patients , 2013, European Journal of Nuclear Medicine and Molecular Imaging.

[37]  Carlo Catalano,et al.  Real-time magnetic resonance-guided high-intensity focused ultrasound focal therapy for localised prostate cancer: preliminary experience. , 2013, European urology.

[38]  Thomas Hambrock,et al.  Three-Tesla magnetic resonance-guided prostate biopsy in men with increased prostate-specific antigen and repeated, negative, random, systematic, transrectal ultrasound biopsies: detection of clinically significant prostate cancers. , 2012, European urology.

[39]  M. Preston,et al.  Prostate cancer imaging: what the urologist wants to know. , 2012, Radiologic clinics of North America.

[40]  R. Memo,et al.  Shear Wave Ultrasound Elastography of the Prostate: Initial Results , 2012, Ultrasound quarterly.

[41]  Aaron Fenster,et al.  A molecular image-directed, 3D ultrasound-guided biopsy system for the prostate , 2012, Medical Imaging.

[42]  Giuseppe Palermo,et al.  Imaging in Prostate Cancer Staging: Present Role and Future Perspectives , 2012, Urologia Internationalis.

[43]  K. Fareed,et al.  Office based transrectal saturation biopsy improves prostate cancer detection compared to extended biopsy in the repeat biopsy population. , 2011, The Journal of urology.

[44]  T. Sone,et al.  Locally recurrent prostate cancer after high-dose-rate brachytherapy: the value of diffusion-weighted imaging, dynamic contrast-enhanced MRI, and T2-weighted imaging in localizing tumors. , 2011, AJR. American journal of roentgenology.

[45]  P. Waldenberger,et al.  18F choline PET/CT in the preoperative staging of prostate cancer in patients with intermediate or high risk of extracapsular disease: a prospective study of 130 patients. , 2010, Radiology.

[46]  T. Schlomm,et al.  Evaluation of prostate cancer detection with ultrasound real-time elastography: a comparison with step section pathological analysis after radical prostatectomy. , 2008, European urology.

[47]  E. Adang,et al.  The diagnostic accuracy of CT and MRI in the staging of pelvic lymph nodes in patients with prostate cancer: a meta-analysis. , 2008, Clinical radiology.

[48]  P. Therasse,et al.  Magnetic resonance imaging of the axial skeleton for detecting bone metastases in patients with high-risk prostate cancer: diagnostic and cost-effectiveness and comparison with current detection strategies. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[49]  G. Bartsch,et al.  Real‐time elastography for detecting prostate cancer: preliminary experience , 2007, BJU international.

[50]  U. Metser,et al.  The detection of bone metastases in patients with high-risk prostate cancer: 99mTc-MDP Planar bone scintigraphy, single- and multi-field-of-view SPECT, 18F-fluoride PET, and 18F-fluoride PET/CT. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[51]  E. Halpern,et al.  Contrast-enhanced ultrasound imaging of prostate cancer. , 2006, Reviews in urology.

[52]  N. Gürmen,et al.  The effectiveness of imaging modalities in clinical staging of localized prostatic carcinoma , 2006, International Urology and Nephrology.

[53]  H. Hricak,et al.  MR imaging and MR spectroscopic imaging in the pre-treatment evaluation of prostate cancer. , 2005, The British journal of radiology.

[54]  H. Lukka,et al.  Baseline staging of newly diagnosed prostate cancer: a summary of the literature. , 2004, The Journal of urology.

[55]  L. Türkeri,et al.  Important preoperative prognostic factors for extracapsular extension, seminal vesicle invasion and lymph node involvement in cases with radical retropubic prostatectomy , 2004, International Urology and Nephrology.

[56]  Ralph Weissleder,et al.  Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. , 2003, The New England journal of medicine.

[57]  J. Moul,et al.  Limited value of bone scintigraphy and computed tomography in assessing biochemical failure after radical prostatectomy. , 2003, Urology.

[58]  Jelle O. Barentsz,et al.  Local staging of prostate cancer using magnetic resonance imaging: a meta-analysis , 2002, European Radiology.

[59]  S. Shariat,et al.  Local recurrence after radical prostatectomy: correlation of US features with prostatic fossa biopsy findings. , 2001, Radiology.